A variety of new chemical materials were selected, and Dalian's "14th Five-Year Plan" petrochemical industry development plan was released
Time of Update: 2022-01-24
Recently, the Dalian Municipal People's Government released Dalian's "14th Five-Year" petrochemical industry development plan on its official website . According to the plan, by 2025, Dalian will b
Youzhiyou BioCD38xCD3 dual-specific antibody new drug has been approved clinically
Time of Update: 2021-03-10
China's State Drug Administration (NMPA) Drug Review Center (CDE) recently announced that Youzhiyou Biological research and development of "injection recombinant anti-CD38 and CD3 dual specific antibodies" (research and development code: Y150) to obtain a clinical trial implied license, the adaptive disease is multiple myeloma (MM).
11 science and technology board pharmaceutical companies announced the first three quarters of the results forecast, more than 30% of the expected
Time of Update: 2020-11-15
: Expected net profit growth of 41.43 percent to 49.29 percent was followed by pre-tech bio, which forecast net profit of $270 million to $285 million in the first three quarters, up 41.43 percent from a year earlier to 49.29 percent.
Xinda hired Liu Yongjun as group president Junshi core technical personnel Wu Hai left
Time of Update: 2020-10-22
October 13th, Junshi Bio announced that Mr. HAIWU (Wu Hai), a director, deputy general manager and core technical staff member of the company, had applied to resign as deputy general manager of the company on the same day for personal reasons.
Plum Bio's annual revenue is first broken by 10 billion business focus shifted to amino acids
Time of Update: 2020-07-29
On March 1, Meihua Bio (600873.SH) released its 2015 annual report, with operating income of approximately RMB11,853 million, up 20.15 percent from RMB9.865 billion in 2014 The capital market is conc
Antibiotic R & D company motif bio will be listed in the UK
Time of Update: 2015-02-03
Source: Ding Xiangyuan 2015-02-03 motif biological mainly develops various antibiotics The company plans to raise at least 4 million pounds, or even up to 16 million pounds, by listing on the A-share
China's prescription drug market is expected to reach US $315 billion in 2020
Time of Update: 2013-11-18
Source: Jim Greenwood, President and CEO of global biotechnology industry organization, China industry research network, November 15, 2013, said at the third bio China Bio Industry conference recently